美克
chinese
隐藏导航
x
Search
logo
News Center
NEWS CENTER
Homepage
/
Newsroom
/
Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

  • Categories:Newsroom
  • Author:
  • Origin:
  • Time of issue:2022-07-19
  • Views:0

(Summary description)      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 


Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

(Summary description)      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 


  • Categories:Newsroom
  • Author:
  • Origin:
  • Time of issue:2022-07-19
  • Views:0
Information

      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 

Scan the QR code to read on your phone

Previous: Medomics Medical contributes to global epidemic prevention and control, and has been approved two more certifications
Next: Nearly 10 million test kits were released quickly, Medomics Medical helped Hong Kong to fight the epidemic
Previous: Medomics Medical contributes to global epidemic prevention and control, and has been approved two more certifications
Next: Nearly 10 million test kits were released quickly, Medomics Medical helped Hong Kong to fight the epidemic
APALT

FOLLOW MEDOMICS

APALT

Product Center

Infectious Disease

Jiangsu Medomics Medical Technology Co,Ltd    Powered By www.300.cn